ArticleFrontiers in oncology2021

The Interplay Between Programmed Death Ligand 1 and Vimentin in Advanced Non-Small-Cell Lung Cancer.

Giuseppe Bronte et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.